GWENDOLYN WRIGHT: Open Payments
NPI 1467832246 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,139 in 140 payments from 20 companies in 2025. Trend: 2023 $5,529 · 2024 $11,686 · 2025 $25,139
Speaker / faculty: $13,134Travel & lodging: $4,460Food & beverage: $3,884Consulting: $3,616Education: $46
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $8,816 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $7,169 |
| ABBVIE INC. | 33 | $3,612 |
| GENZYME CORPORATION | 8 | $3,022 |
| Ipsen Biopharmaceuticals, Inc | 9 | $1,174 |
| Regeneron Healthcare Solutions, Inc. | 7 | $253 |
| Janssen Biotech, Inc. | 7 | $199 |
| Ardelyx, Inc. | 4 | $154 |
| Intercept Pharmaceuticals, Inc. | 2 | $135 |
| Lilly USA, LLC | 5 | $108 |
Products named: ENTYVIO, XIFAXAN, LINZESS, TRULANCE, Bylvay, DUPIXENT, SKYRIZI, RINVOQ.
Industry payments across MI — which companies pay providers there.
